| scholarly article | Q13442814 |
| P50 | author | Andrei Krivtsov | Q55167983 |
| Christian Bach | Q58032682 | ||
| P2093 | author name string | Hong Zhang | |
| Daniel G Tenen | |||
| Henry Yang | |||
| Robert S Welner | |||
| Philipp B Staber | |||
| Scott A Armstrong | |||
| Junyan Zhang | |||
| Min Ye | |||
| Elena Levantini | |||
| Richard Koche | |||
| Monica Cusan | |||
| P2860 | cites work | MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function | Q24557551 |
| Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization | Q24603527 | ||
| Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha | Q28589867 | ||
| IDH mutation impairs histone demethylation and results in a block to cell differentiation | Q29305058 | ||
| Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia | Q33686199 | ||
| T cell development requires constraint of the myeloid regulator C/EBP-α by the Notch target and transcriptional repressor Hes1. | Q33687647 | ||
| Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. | Q33711497 | ||
| C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis | Q33919670 | ||
| The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells | Q34318485 | ||
| Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position | Q34375601 | ||
| Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia | Q34403931 | ||
| PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2 | Q34577769 | ||
| Is CCAAT/enhancer-binding protein a central regulator of energy metabolism? | Q34661217 | ||
| Impaired Energy Homeostasis in C/EBPα Knockout Mice | Q34662358 | ||
| Immunogenetics. Chromatin state dynamics during blood formation | Q35546671 | ||
| C/EBPalpha mutations in acute myeloid leukaemias | Q35762456 | ||
| BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia | Q35762941 | ||
| MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. | Q35898171 | ||
| Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture | Q36380522 | ||
| Notch pathway activation targets AML-initiating cell homeostasis and differentiation | Q36603527 | ||
| C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence | Q37192706 | ||
| STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2. | Q37565082 | ||
| Initiation of MLL-rearranged AML is dependent on C/EBPα | Q38310200 | ||
| Clonal development of the acute leukemias. | Q38624784 | ||
| Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML. | Q39781275 | ||
| Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. | Q40219637 | ||
| Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. | Q40252270 | ||
| C/EBP alpha: a critical regulator of genes governing integrative metabolic processes | Q41005354 | ||
| Transcription factors, normal myeloid development, and leukemia | Q41534189 | ||
| Common and overlapping oncogenic pathways contribute to the evolution of acute myeloid leukemias | Q42010591 | ||
| MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. | Q53362332 | ||
| C/EBPbeta is required for 'emergency' granulopoiesis. | Q53619729 | ||
| Modeling of C/EBPα Mutant Acute Myeloid Leukemia Reveals a Common Expression Signature of Committed Myeloid Leukemia-Initiating Cells | Q57615422 | ||
| Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells | Q59599864 | ||
| Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia | Q64008436 | ||
| Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia | Q71099953 | ||
| Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family | Q77483328 | ||
| Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells | Q81394615 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 611-623 | |
| P577 | publication date | 2015-09-24 | |
| P1433 | published in | Cell Stem Cell | Q2943975 |
| P1476 | title | Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia | |
| P478 | volume | 17 |
| Q64905283 | A Transcription Factor Addiction in Leukemia Imposed by the MLL Promoter Sequence. |
| Q48310031 | A novel prospective isolation of murine fetal liver progenitors to study in utero hematopoietic defects. |
| Q34047994 | Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia |
| Q38761783 | Biology and relevance of human acute myeloid leukemia stem cells |
| Q34046454 | C/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4. |
| Q39442731 | C/EBPα deregulation as a paradigm for leukemogenesis |
| Q87757676 | C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia |
| Q36079807 | Context Matters: Distinct Disease Outcomes as a Result of Crebbp Hemizygosity in Different Mouse Bone Marrow Compartments |
| Q38852979 | Deregulation of the HOXA9/MEIS1 axis in acute leukemia |
| Q92711438 | Detect accessible chromatin using ATAC-sequencing, from principle to applications |
| Q67200898 | Developmental origins and emerging therapeutic opportunities for childhood cancer |
| Q90371841 | Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML |
| Q40022463 | GFI1 as a novel prognostic and therapeutic factor for AML/MDS. |
| Q47428832 | Gain-of-function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies. |
| Q30252934 | Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability. |
| Q41113548 | How does C/EBPα speed up cell reprogramming? |
| Q38721210 | Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. |
| Q93344389 | IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation |
| Q35944184 | In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis |
| Q91704512 | Infection perturbs Bach2- and Bach1-dependent erythroid lineage 'choice' to cause anemia |
| Q49913945 | LSD1 inhibition exerts its anti-leukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML. |
| Q49380618 | Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fates |
| Q33802946 | Loss of Asxl2 leads to myeloid malignancies in mice |
| Q52721699 | Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo. |
| Q92095622 | MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors |
| Q55279675 | MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. |
| Q91452449 | MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells |
| Q89393874 | Modeling ASXL1 mutation revealed impaired hematopoiesis caused by derepression of p16Ink4a through aberrant PRC1-mediated histone modification |
| Q61797736 | Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells |
| Q91558662 | Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia |
| Q38777440 | On the potential role of DNMT1 in acute myeloid leukemia and myelodysplastic syndromes: not another mutated epigenetic driver |
| Q39341523 | Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality |
| Q39209792 | Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia |
| Q47284426 | R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling. |
| Q42290133 | Stat5 deficiency decreases transcriptional heterogeneity and supports emergence of hematopoietic sub-populations |
| Q36247415 | The Janus-faced Nature of miR-22 in Hematopoiesis: Is It an Oncogenic Tumor Suppressor or Rather a Tumor-Suppressive Oncogene? |
| Q92205729 | The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model |
| Q93026578 | The cell of origin and the leukemia stem cell in acute myeloid leukemia |
| Q38715114 | The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment |
| Q34502869 | The multifaceted functions of C/EBPα in normal and malignant haematopoiesis. |
| Q53939018 | Trib2 expression in granulocyte-monocyte progenitors drives a highly drug resistant acute myeloid leukaemia linked to elevated Bcl2. |
| Q64942073 | Understanding the molecular basis of acute myeloid leukemias: where are we now? |
| Q42324924 | Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP. |
| Q91812845 | m6A-binding proteins: the emerging crucial performers in epigenetics |
| Q39039867 | miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism |
| Q55248017 | miR-143/145 differentially regulate hematopoietic stem and progenitor activity through suppression of canonical TGFβ signaling. |
Search more.